Showing results (761-770 of 2,106) with videos related to
Sort By:
Pageof 211
CNS Drugs|April 11, 2012
Minocycline: therapeutic potential in psychiatryOlivia M Dean, João Data-Franco, Francesco Giorlando, et al.CNS Drugs|November 9, 2014
Glycogen synthase kinase-3 as a therapeutic target for cognitive dysfunction in neuropsychiatric disordersOlivia O'Leary, Yvonne NolanCNS Drugs|October 18, 2014
Rasagiline: a review of its use in the treatment of idiopathic Parkinson's diseasePaul L McCormackCNS Drugs|October 20, 2014
Alteplase in acute ischemic stroke: putting the guidelines into practiceNandakumar Nagaraja, Harold P AdamsCNS Drugs|July 31, 2001
The new generation of GABA enhancers. Potential in the treatment of epilepsyS J Czuczwar, P N PatsalosCNS Drugs|November 9, 2001
Reducing bleeding complications after thrombolytic therapy for stroke: clinical potential of metalloproteinase inhibitors and spin trap agentsP A Lapchak, D M AraujoCNS Drugs|July 21, 2001
Neuroprotection for ischaemic stroke: an unattainable goal?D S Liebeskind, S E KasnerCNS Drugs|July 21, 2001
The role of central serotonergic dysfunction in the aetiology of premenstrual dysphoric disorder: therapeutic implicationsB L ParryCNS Drugs|August 29, 2001
Brain and spinal cord atrophy in multiple sclerosis: role as a surrogate measure of disease progressionJ H SimonPageof 211